家族性大腸腺腫症治療の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE3738)
◆英語タイトル:Global Familial Adenomatous Polyposis Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE3738
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月
◆ページ数:89
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥444,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥666,900見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥889,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、家族性大腸腺腫症治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(イコサペント、塩酸エフロルニチン、アスピリン、CEQ-508、その他)、用途別市場規模(診療所、病院、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・家族性大腸腺腫症治療の市場動向
・企業の競争状況、市場シェア
・家族性大腸腺腫症治療の種類別市場規模(イコサペント、塩酸エフロルニチン、アスピリン、CEQ-508、その他)
・家族性大腸腺腫症治療の用途別市場規模(診療所、病院、その他)
・家族性大腸腺腫症治療の北米市場規模2016-2027(アメリカ、カナダ)
・家族性大腸腺腫症治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・家族性大腸腺腫症治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・家族性大腸腺腫症治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・家族性大腸腺腫症治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Cancer Prevention Pharmaceuticals Inc、Marina Biotech Inc、Thetis Pharmaceuticals LLC)
・結論
【レポートの概要】

Market Analysis and Insights: Global Familial Adenomatous Polyposis Treatment Market
The global Familial Adenomatous Polyposis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Familial Adenomatous Polyposis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Familial Adenomatous Polyposis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Familial Adenomatous Polyposis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Familial Adenomatous Polyposis Treatment market.

Global Familial Adenomatous Polyposis Treatment Scope and Market Size
Familial Adenomatous Polyposis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Familial Adenomatous Polyposis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Icosapent
Eflornithine Hydrochloride
Aspirin
CEQ-508
Others

Segment by Application
Clinic
Hospital
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Cancer Prevention Pharmaceuticals Inc
Marina Biotech Inc
Thetis Pharmaceuticals LLC

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Familial Adenomatous Polyposis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Icosapent
1.2.3 Eflornithine Hydrochloride
1.2.4 Aspirin
1.2.5 CEQ-508
1.2.6 Others
1.3 Market by Application
1.3.1 Global Familial Adenomatous Polyposis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Familial Adenomatous Polyposis Treatment Market Perspective (2016-2027)
2.2 Familial Adenomatous Polyposis Treatment Growth Trends by Regions
2.2.1 Familial Adenomatous Polyposis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Familial Adenomatous Polyposis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Familial Adenomatous Polyposis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Familial Adenomatous Polyposis Treatment Industry Dynamic
2.3.1 Familial Adenomatous Polyposis Treatment Market Trends
2.3.2 Familial Adenomatous Polyposis Treatment Market Drivers
2.3.3 Familial Adenomatous Polyposis Treatment Market Challenges
2.3.4 Familial Adenomatous Polyposis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Familial Adenomatous Polyposis Treatment Players by Revenue
3.1.1 Global Top Familial Adenomatous Polyposis Treatment Players by Revenue (2016-2021)
3.1.2 Global Familial Adenomatous Polyposis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Familial Adenomatous Polyposis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Familial Adenomatous Polyposis Treatment Revenue
3.4 Global Familial Adenomatous Polyposis Treatment Market Concentration Ratio
3.4.1 Global Familial Adenomatous Polyposis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Familial Adenomatous Polyposis Treatment Revenue in 2020
3.5 Familial Adenomatous Polyposis Treatment Key Players Head office and Area Served
3.6 Key Players Familial Adenomatous Polyposis Treatment Product Solution and Service
3.7 Date of Enter into Familial Adenomatous Polyposis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Familial Adenomatous Polyposis Treatment Breakdown Data by Type
4.1 Global Familial Adenomatous Polyposis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Familial Adenomatous Polyposis Treatment Forecasted Market Size by Type (2022-2027)

5 Familial Adenomatous Polyposis Treatment Breakdown Data by Application
5.1 Global Familial Adenomatous Polyposis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Familial Adenomatous Polyposis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Familial Adenomatous Polyposis Treatment Market Size (2016-2027)
6.2 North America Familial Adenomatous Polyposis Treatment Market Size by Type
6.2.1 North America Familial Adenomatous Polyposis Treatment Market Size by Type (2016-2021)
6.2.2 North America Familial Adenomatous Polyposis Treatment Market Size by Type (2022-2027)
6.2.3 North America Familial Adenomatous Polyposis Treatment Market Size by Type (2016-2027)
6.3 North America Familial Adenomatous Polyposis Treatment Market Size by Application
6.3.1 North America Familial Adenomatous Polyposis Treatment Market Size by Application (2016-2021)
6.3.2 North America Familial Adenomatous Polyposis Treatment Market Size by Application (2022-2027)
6.3.3 North America Familial Adenomatous Polyposis Treatment Market Size by Application (2016-2027)
6.4 North America Familial Adenomatous Polyposis Treatment Market Size by Country
6.4.1 North America Familial Adenomatous Polyposis Treatment Market Size by Country (2016-2021)
6.4.2 North America Familial Adenomatous Polyposis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Familial Adenomatous Polyposis Treatment Market Size (2016-2027)
7.2 Europe Familial Adenomatous Polyposis Treatment Market Size by Type
7.2.1 Europe Familial Adenomatous Polyposis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Familial Adenomatous Polyposis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Familial Adenomatous Polyposis Treatment Market Size by Type (2016-2027)
7.3 Europe Familial Adenomatous Polyposis Treatment Market Size by Application
7.3.1 Europe Familial Adenomatous Polyposis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Familial Adenomatous Polyposis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Familial Adenomatous Polyposis Treatment Market Size by Application (2016-2027)
7.4 Europe Familial Adenomatous Polyposis Treatment Market Size by Country
7.4.1 Europe Familial Adenomatous Polyposis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Familial Adenomatous Polyposis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size by Type
8.2.1 Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size by Application
8.3.1 Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size by Region
8.4.1 Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Familial Adenomatous Polyposis Treatment Market Size (2016-2027)
9.2 Latin America Familial Adenomatous Polyposis Treatment Market Size by Type
9.2.1 Latin America Familial Adenomatous Polyposis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Familial Adenomatous Polyposis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Familial Adenomatous Polyposis Treatment Market Size by Type (2016-2027)
9.3 Latin America Familial Adenomatous Polyposis Treatment Market Size by Application
9.3.1 Latin America Familial Adenomatous Polyposis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Familial Adenomatous Polyposis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Familial Adenomatous Polyposis Treatment Market Size by Application (2016-2027)
9.4 Latin America Familial Adenomatous Polyposis Treatment Market Size by Country
9.4.1 Latin America Familial Adenomatous Polyposis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Familial Adenomatous Polyposis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size by Type
10.2.1 Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size by Application
10.3.1 Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size by Country
10.4.1 Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Cancer Prevention Pharmaceuticals Inc
11.1.1 Cancer Prevention Pharmaceuticals Inc Company Details
11.1.2 Cancer Prevention Pharmaceuticals Inc Business Overview
11.1.3 Cancer Prevention Pharmaceuticals Inc Familial Adenomatous Polyposis Treatment Introduction
11.1.4 Cancer Prevention Pharmaceuticals Inc Revenue in Familial Adenomatous Polyposis Treatment Business (2016-2021)
11.1.5 Cancer Prevention Pharmaceuticals Inc Recent Development
11.2 Marina Biotech Inc
11.2.1 Marina Biotech Inc Company Details
11.2.2 Marina Biotech Inc Business Overview
11.2.3 Marina Biotech Inc Familial Adenomatous Polyposis Treatment Introduction
11.2.4 Marina Biotech Inc Revenue in Familial Adenomatous Polyposis Treatment Business (2016-2021)
11.2.5 Marina Biotech Inc Recent Development
11.3 Thetis Pharmaceuticals LLC
11.3.1 Thetis Pharmaceuticals LLC Company Details
11.3.2 Thetis Pharmaceuticals LLC Business Overview
11.3.3 Thetis Pharmaceuticals LLC Familial Adenomatous Polyposis Treatment Introduction
11.3.4 Thetis Pharmaceuticals LLC Revenue in Familial Adenomatous Polyposis Treatment Business (2016-2021)
11.3.5 Thetis Pharmaceuticals LLC Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Familial Adenomatous Polyposis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Icosapent
Table 3. Key Players of Eflornithine Hydrochloride
Table 4. Key Players of Aspirin
Table 5. Key Players of CEQ-508
Table 6. Key Players of Others
Table 7. Global Familial Adenomatous Polyposis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Familial Adenomatous Polyposis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Familial Adenomatous Polyposis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Familial Adenomatous Polyposis Treatment Market Share by Regions (2016-2021)
Table 11. Global Familial Adenomatous Polyposis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Familial Adenomatous Polyposis Treatment Market Share by Regions (2022-2027)
Table 13. Familial Adenomatous Polyposis Treatment Market Trends
Table 14. Familial Adenomatous Polyposis Treatment Market Drivers
Table 15. Familial Adenomatous Polyposis Treatment Market Challenges
Table 16. Familial Adenomatous Polyposis Treatment Market Restraints
Table 17. Global Familial Adenomatous Polyposis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Familial Adenomatous Polyposis Treatment Market Share by Players (2016-2021)
Table 19. Global Top Familial Adenomatous Polyposis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Familial Adenomatous Polyposis Treatment as of 2020)
Table 20. Ranking of Global Top Familial Adenomatous Polyposis Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Familial Adenomatous Polyposis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Familial Adenomatous Polyposis Treatment Product Solution and Service
Table 24. Date of Enter into Familial Adenomatous Polyposis Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Familial Adenomatous Polyposis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Familial Adenomatous Polyposis Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Familial Adenomatous Polyposis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Familial Adenomatous Polyposis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Familial Adenomatous Polyposis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Familial Adenomatous Polyposis Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Familial Adenomatous Polyposis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Familial Adenomatous Polyposis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Familial Adenomatous Polyposis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Familial Adenomatous Polyposis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Familial Adenomatous Polyposis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Familial Adenomatous Polyposis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Familial Adenomatous Polyposis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Familial Adenomatous Polyposis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Familial Adenomatous Polyposis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Familial Adenomatous Polyposis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Familial Adenomatous Polyposis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Familial Adenomatous Polyposis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Familial Adenomatous Polyposis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Familial Adenomatous Polyposis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Familial Adenomatous Polyposis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Familial Adenomatous Polyposis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Familial Adenomatous Polyposis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Familial Adenomatous Polyposis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Familial Adenomatous Polyposis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Familial Adenomatous Polyposis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Cancer Prevention Pharmaceuticals Inc Company Details
Table 65. Cancer Prevention Pharmaceuticals Inc Business Overview
Table 66. Cancer Prevention Pharmaceuticals Inc Familial Adenomatous Polyposis Treatment Product
Table 67. Cancer Prevention Pharmaceuticals Inc Revenue in Familial Adenomatous Polyposis Treatment Business (2016-2021) & (US$ Million)
Table 68. Cancer Prevention Pharmaceuticals Inc Recent Development
Table 69. Marina Biotech Inc Company Details
Table 70. Marina Biotech Inc Business Overview
Table 71. Marina Biotech Inc Familial Adenomatous Polyposis Treatment Product
Table 72. Marina Biotech Inc Revenue in Familial Adenomatous Polyposis Treatment Business (2016-2021) & (US$ Million)
Table 73. Marina Biotech Inc Recent Development
Table 74. Thetis Pharmaceuticals LLC Company Details
Table 75. Thetis Pharmaceuticals LLC Business Overview
Table 76. Thetis Pharmaceuticals LLC Familial Adenomatous Polyposis Treatment Product
Table 77. Thetis Pharmaceuticals LLC Revenue in Familial Adenomatous Polyposis Treatment Business (2016-2021) & (US$ Million)
Table 78. Thetis Pharmaceuticals LLC Recent Development
Table 79. Research Programs/Design for This Report
Table 80. Key Data Information from Secondary Sources
Table 81. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Familial Adenomatous Polyposis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Icosapent Features
Figure 3. Eflornithine Hydrochloride Features
Figure 4. Aspirin Features
Figure 5. CEQ-508 Features
Figure 6. Others Features
Figure 7. Global Familial Adenomatous Polyposis Treatment Market Share by Application: 2020 VS 2027
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Others Case Studies
Figure 11. Familial Adenomatous Polyposis Treatment Report Years Considered
Figure 12. Global Familial Adenomatous Polyposis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Familial Adenomatous Polyposis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Familial Adenomatous Polyposis Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Familial Adenomatous Polyposis Treatment Market Share by Regions (2022-2027)
Figure 16. Global Familial Adenomatous Polyposis Treatment Market Share by Players in 2020
Figure 17. Global Top Familial Adenomatous Polyposis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Familial Adenomatous Polyposis Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Familial Adenomatous Polyposis Treatment Revenue in 2020
Figure 19. Global Familial Adenomatous Polyposis Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Familial Adenomatous Polyposis Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Familial Adenomatous Polyposis Treatment Market Share by Type (2016-2027)
Figure 23. North America Familial Adenomatous Polyposis Treatment Market Share by Application (2016-2027)
Figure 24. North America Familial Adenomatous Polyposis Treatment Market Share by Country (2016-2027)
Figure 25. United States Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Familial Adenomatous Polyposis Treatment Market Share by Type (2016-2027)
Figure 29. Europe Familial Adenomatous Polyposis Treatment Market Share by Application (2016-2027)
Figure 30. Europe Familial Adenomatous Polyposis Treatment Market Share by Country (2016-2027)
Figure 31. Germany Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Familial Adenomatous Polyposis Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Familial Adenomatous Polyposis Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Familial Adenomatous Polyposis Treatment Market Share by Region (2016-2027)
Figure 41. China Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Familial Adenomatous Polyposis Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Familial Adenomatous Polyposis Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Familial Adenomatous Polyposis Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Familial Adenomatous Polyposis Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Familial Adenomatous Polyposis Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Familial Adenomatous Polyposis Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Familial Adenomatous Polyposis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Cancer Prevention Pharmaceuticals Inc Revenue Growth Rate in Familial Adenomatous Polyposis Treatment Business (2016-2021)
Figure 61. Marina Biotech Inc Revenue Growth Rate in Familial Adenomatous Polyposis Treatment Business (2016-2021)
Figure 62. Thetis Pharmaceuticals LLC Revenue Growth Rate in Familial Adenomatous Polyposis Treatment Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 家族性大腸腺腫症治療の世界市場規模・現状・予測2021年-2027年(Global Familial Adenomatous Polyposis Treatment Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。